Whole-mount immunolabeling enabled high-resolution visualization of peripheral nerve infiltration patterns within melanoma, ...

Nerve fibers within melanomas can slow their growth, according to a study led by Weill Cornell Medicine investigators. The ...

The company will use the funds to accelerate its clinical programs and prepare for commercialization of its neuromodulation ...

Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced that the company will be ...

However, a new study has identified a surprising “brake.” Investigating melanoma in mouse models, the team discovered that sympathetic nerves, the same ones responsible for the “fight-or-flight” ...

Nervonik, Inc., a clinical-stage medical device company developing next-generation peripheral nerve stimulation (PNS) technologies, today announced the closing of an oversubscribed $52.5 million ...

Nervonik announced today that it closed an oversubscribed Series B financing round worth proceeds of $52.5 million.

Please provide your email address to receive an email when new articles are posted on . Patients used the device for 60 days, and effects persisted for 6 months. 71% of patients reported improved Neck ...

Leg tingling, numbness, pain, and cramping can be easy to dismiss, but they may point to circulation problems such as ...

Nervonik raises $52.5M in Series B funding to advance its peripheral nerve stimulation technology and expand innovative ...

This healthcare firm develops nerve repair solutions for hospitals and specialists in the U.S. and select global markets.

Nervonik has secured $52.5 million in Series B funding to accelerate development and commercialization of its peripheral nerve stimulation platform, which integrates real-time sensing for precise pain ...